TIDMAMS

RNS Number : 1032C

Advanced Medical Solutions Grp PLC

10 April 2017

 
 
     10 April 2017 
 

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Director/PDMR and PCA Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced wound care markets, announces that the Board, following a recommendation from the Remuneration Committee, has granted new share options to the following Directors and PDMRs under the Advanced Medical Solutions Long Term Incentive Plan (the 'LTIP') on 6 April 2017. The vesting period of these options is subject to certain performance criteria over a three year period.

 
 Director/PDMR       Options prior   Options granted   Resultant 
                      to grant                          holding 
==================  ==============  ================  ========== 
 Chris Meredith 
  Chief Executive 
  Officer            968,436         109,571           1,078,007 
==================  ==============  ================  ========== 
 Mary Tavener 
  Chief Financial 
  Officer            591,199         84,762            675,961 
==================  ==============  ================  ========== 
 Simon Coates 
  PDMR               91,864          17,891            109,755 
==================  ==============  ================  ========== 
 Rose Guang 
  PDMR               138,011         24,067            162,078 
==================  ==============  ================  ========== 
 Eddie Johnson 
  PDMR               120,364         23,775            144,139 
==================  ==============  ================  ========== 
 Pieter van 
  Hoof 
  PDMR               121,505         23,428            144,933 
==================  ==============  ================  ========== 
 Becky Walmsley 
  PDMR               50,000          23,082            73,082 
==================  ==============  ================  ========== 
 Jeff Willis 
  PDMR               132,044         40,550            172,594 
==================  ==============  ================  ========== 
 

Advanced Medical Solutions Group plc also announces that on 6 April 2017, the Board, following a recommendation from the Remuneration Committee, granted new share options to the following Directors under the Advanced Medical Solutions Deferred Annual Bonus Plan (the '2014 DAB').

This award is in respect of the part of their bonus that the Directors and PDMRs are compulsorily required to defer for the 2016 financial year. These options vest at the end of three years.

 
 Director/PDMR       Options prior   Options granted   Resultant 
                      to grant                          holding 
==================  ==============  ================  ========== 
 Chris Meredith 
  Chief Executive 
  Officer            82,218          23,369            105,587 
==================  ==============  ================  ========== 
 Mary Tavener 
  Chief Financial 
  Officer            57,870          15,065            72,935 
==================  ==============  ================  ========== 
 Simon Coates 
  PDMR               4,438           3,306             7,744 
==================  ==============  ================  ========== 
 Rose Guang 
  PDMR               12,586          4,612             17,198 
==================  ==============  ================  ========== 
 Eddie Johnson 
  PDMR               14,803          4,556             19,359 
==================  ==============  ================  ========== 
 Pieter van 
  Hoof 
  PDMR               13,490          4,329             17,819 
==================  ==============  ================  ========== 
 Becky Walmsley 
  PDMR               1,067           4,114             5,181 
==================  ==============  ================  ========== 
 Jeff Willis 
  PDMR               17,996          5,535             23,531 
==================  ==============  ================  ========== 
 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  --------------------------------------------------------------- 
 a)   Name: Chris Meredith 
---  --------------------------------------------------------------- 
 2.   Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  --------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  --------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  --------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  --------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  --------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Grant of 109,571 options under the Advanced Medical 
                Solutions Long Term Incentive Plan on 6 April 2017 
 
 
           *    Grant of 23,369 options under the Advanced Medical 
                Solutions Deferred Annual Bonus Plan on 6 April 2017 
---  --------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)   Volume(s) 
       ---------  ---------- 
        n/a        n/a 
       ---------  ---------- 
---  --------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: n/a 
       Aggregated price: n/a 
---  --------------------------------------------------------------- 
 e)   Date of the transaction: 06/04/2017 
---  --------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  --------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  --------------------------------------------------------------- 
 a)   Name: Mary Tavener 
---  --------------------------------------------------------------- 
 2.   Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  --------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  --------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  --------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  --------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  --------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Grant of 84,762 options under the Advanced Medical 
                Solutions Long Term Incentive Plan on 6 April 2017 
 
 
           *    Grant of 15,065 options under the Advanced Medical 
                Solutions Deferred Annual Bonus Plan on 6 April 2017 
---  --------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)   Volume(s) 
       ---------  ---------- 
        n/a        n/a 
       ---------  ---------- 
---  --------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: n/a 
       Aggregated price: n/a 
---  --------------------------------------------------------------- 
 e)   Date of the transaction: 06/04/2017 
---  --------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  --------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  --------------------------------------------------------------- 
 a)   Name: Simon Coates 
---  --------------------------------------------------------------- 
 2.   Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  --------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  --------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  --------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  --------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  --------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Grant of 17,891 options under the Advanced Medical 
                Solutions Long Term Incentive Plan on 6 April 2017 
 
 
           *    Grant of 3,306 options under the Advanced Medical 
                Solutions Deferred Annual Bonus Plan on 6 April 2017 
---  --------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)   Volume(s) 
       ---------  ---------- 
        n/a        n/a 
       ---------  ---------- 
---  --------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: n/a 
       Aggregated price: n/a 
---  --------------------------------------------------------------- 
 e)   Date of the transaction: 06/04/2017 
---  --------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  --------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  --------------------------------------------------------------- 
 a)   Name: Rose Guang 
---  --------------------------------------------------------------- 
 2.   Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  --------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  --------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  --------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  --------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  --------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Grant of 24,067 options under the Advanced Medical 
                Solutions Long Term Incentive Plan on 6 April 2017 
 
 
           *    Grant of 4,612 options under the Advanced Medical 
                Solutions Deferred Annual Bonus Plan on 6 April 2017 
---  --------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)   Volume(s) 
       ---------  ---------- 
        n/a        n/a 
       ---------  ---------- 
---  --------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: n/a 
       Aggregated price: n/a 
---  --------------------------------------------------------------- 
 e)   Date of the transaction: 06/04/2017 
---  --------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  --------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  --------------------------------------------------------------- 
 a)   Name: Eddie Johnson 
---  --------------------------------------------------------------- 
 2.   Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  --------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  --------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  --------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  --------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  --------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Grant of 23,775 options under the Advanced Medical 
                Solutions Long Term Incentive Plan on 6 April 2017 
 
 
           *    Grant of 4,556 options under the Advanced Medical 
                Solutions Deferred Annual Bonus Plan on 6 April 2017 
---  --------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)   Volume(s) 
       ---------  ---------- 
        n/a        n/a 
       ---------  ---------- 
---  --------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: n/a 
       Aggregated price: n/a 
---  --------------------------------------------------------------- 
 e)   Date of the transaction: 06/04/2017 
---  --------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  --------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  --------------------------------------------------------------- 
 a)   Name: Pieter van Hoof 
---  --------------------------------------------------------------- 
 2.   Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  --------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  --------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  --------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  --------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  --------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Grant of 23,428 options under the Advanced Medical 
                Solutions Long Term Incentive Plan on 6 April 2017 
 
 
           *    Grant of 4,329 options under the Advanced Medical 
                Solutions Deferred Annual Bonus Plan on 6 April 2017 
---  --------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)   Volume(s) 
       ---------  ---------- 
        n/a        n/a 
       ---------  ---------- 
---  --------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: n/a 
       Aggregated price: n/a 
---  --------------------------------------------------------------- 
 e)   Date of the transaction: 06/04/2017 
---  --------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  --------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  --------------------------------------------------------------- 
 a)   Name: Becky Walmsley 
---  --------------------------------------------------------------- 
 2.   Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  --------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  --------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  --------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  --------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  --------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Grant of 23,082 options under the Advanced Medical 
                Solutions Long Term Incentive Plan on 6 April 2017 
 
 
           *    Grant of 4,114 options under the Advanced Medical 
                Solutions Deferred Annual Bonus Plan on 6 April 2017 
---  --------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)   Volume(s) 
       ---------  ---------- 
        n/a        n/a 
       ---------  ---------- 
---  --------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: n/a 
       Aggregated price: n/a 
---  --------------------------------------------------------------- 
 e)   Date of the transaction: 06/04/2017 
---  --------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  --------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  --------------------------------------------------------------- 
 a)   Name: Jeff Willis 
---  --------------------------------------------------------------- 
 2.   Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  --------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  --------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  --------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  --------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  --------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Grant of 40,550 options under the Advanced Medical 
                Solutions Long Term Incentive Plan on 6 April 2017 
 
 
           *    Grant of 5,535 options under the Advanced Medical 
                Solutions Deferred Annual Bonus Plan on 6 April 2017 
---  --------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)   Volume(s) 
       ---------  ---------- 
        n/a        n/a 
       ---------  ---------- 
---  --------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: n/a 
       Aggregated price: n/a 
---  --------------------------------------------------------------- 
 e)   Date of the transaction: 06/04/2017 
---  --------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  --------------------------------------------------------------- 
 

- End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                Tel: +44 (0) 
  plc                                             1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Chief Financial 
  Officer 
 
 Consilium Strategic Communications              Tel: +44 (0) 
                                                 20 3709 5700 
 Mary-Jane Elliott / Jonathan         AMS@consilium-comms.com 
  Birt / Matthew Neal / Hendrik 
  Thys 
 
 Investec Bank PLC (NOMAD & Broker)              Tel: +44 (0) 
                                                 20 7597 5970 
 Daniel Adams / Patrick Robb 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal(R) , and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand(R) and RESORBA(R) .

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBSGDSXDBBGRG

(END) Dow Jones Newswires

April 10, 2017 10:26 ET (14:26 GMT)

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Advanced Medical Solutions Charts.
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Advanced Medical Solutions Charts.